The Top Line

December 2, 2022


Listen Later

Biogen recently named Christopher Viehbacher its new CEO, ending a monthslong search to replace Michel Vounatsos. Fraiser Kansteiner and Kevin Dunleavy talk about the current state of the company and recent investor reactions to the new hire. Plus, they discuss a string of other biopharma CEO appointments. 

And, in this episode, we cover the week's news including what Albert Bourla, Ph.D., said that has him in hot water along with a $3.5 million drug, and we tease a possible major acquisition. 

To learn more about topics in this episode:

  • Biogen's incoming CEO Viehbacher gets mixed reviews—and lots of advice—in investor survey 
  • Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line 
  • Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal 
  • Facing a familiar side effect problem, Eisai makes the case for its next Alzheimer's drug after patient deaths
  • Amgen, J&J and Sanofi size up Horizon as Big Pharma renews interest in rare disease M&A 
  • Pfizer CEO Bourla stung by UK's pharma marketing regulator over kids' COVID vax claims: report 
  • GE Healthcare unveils AI program bundle for simplified MRI scans
  • Philips unveils AI-powered platform to improve diagnoses from imaging scans

"The Top Line" is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

See omnystudio.com/listener for privacy information.

...more
View all episodesView all episodes
Download on the App Store

The Top LineBy Fierce Life Sciences

  • 4
  • 4
  • 4
  • 4
  • 4

4

11 ratings


More shows like The Top Line

View all
Planet Money by NPR

Planet Money

30,844 Listeners

Motley Fool Money by The Motley Fool

Motley Fool Money

3,234 Listeners

Exchanges by Goldman Sachs

Exchanges

963 Listeners

Odd Lots by Bloomberg

Odd Lots

1,983 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,657 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,091 Listeners

The Readout Loud by STAT

The Readout Loud

335 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,052 Listeners

Behind the Money by Financial Times

Behind the Money

228 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,087 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

35 Listeners

Economics Explained by Economics Explained

Economics Explained

151 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

21 Listeners

The Markets by Goldman Sachs

The Markets

77 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

141 Listeners